- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 49/16 - AntibodiesImmunoglobulinsFragments thereof
Patent holdings for IPC class A61K 49/16
Total number of patents in this class: 340
10-year publication summary
29
|
31
|
33
|
30
|
34
|
29
|
16
|
16
|
18
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Astellas Pharma Inc. | 1086 |
10 |
OBI Pharma, Inc. | 121 |
9 |
F. Hoffmann-La Roche AG | 7930 |
8 |
Centre National de La Recherche Scientifique | 10418 |
7 |
Commissariat à l'énergie atomique et aux energies alternatives | 10928 |
7 |
Institut Pasteur | 785 |
7 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2847 |
6 |
Purdue Research Foundation | 3593 |
5 |
Annexon, Inc. | 77 |
5 |
Georgia State University Research Foundation, Inc. | 343 |
5 |
University of Southern California | 2115 |
4 |
Biogen International Neuroscience GmbH | 30 |
4 |
On Target Laboratories, LLC | 32 |
4 |
Bioverativ USA Inc. | 41 |
4 |
Genentech, Inc. | 3972 |
3 |
Janssen Pharmaceutica N.V. | 3392 |
3 |
Amgen Inc. | 4073 |
3 |
The Board of Trustees of the Leland Stanford Junior University | 6403 |
3 |
Board of Regents, The University of Texas System | 5782 |
3 |
The Trustees of the University of Pennsylvania | 4317 |
3 |
Other owners | 237 |